-
A, B
Cell viability and percentage of apoptosis in the indicated cell lines under hypoxia were analyzed by trypan blue (A) and PI/Annexin V double staining (B), respectively (n = 3).
-
C, D
The xenograft tumor formation efficiency of the indicated cell lines was assessed, and tumor weight measurements were performed (n = 3).
-
E
Representative images of CRC samples are shown after antibody staining of AcK503‐GDH1 and AcK527‐GDH1.
-
F
The correlation between AcK503‐GDH1 and AcK527‐GDH1 expression in CRC samples. The tissue sections were quantitatively scored according to the percentage of positive cells and the staining intensity (H‐score) (n = 51).
-
G
Representative images of the same CRC samples are shown after staining with antibodies against AcK503/527‐GDH1 and HIF1α.
-
H
Correlation between AcK503/527‐GDH1 and HIF1α expression in CRC samples (n = 21).
-
I
Detection of AcK503/527‐GDH1 expression in CRC grades I + II and III + IV (grade I + II, n = 21; grade III + IV, n = 12).
-
J
Detection of AcK503/527‐GDH1 expression in patients with (+) or without (−) recurrence (−, n = 17; +, n = 17).
-
K
Patient survival corresponding to different levels of AcK503/527‐GDH1 expression (High, n = 38; Low, n = 32).
-
L
PDX growth related to high or low levels of AcK503/527‐GDH1 expression.
-
M
Schematic model described in the discussion section.